Related by context. Frequent words. (Click for all words.) 64 Panzem R 62 R sorafenib tablets 61 CORT # 61 Thiarabine 61 refractory chronic lymphocytic 60 Initiates Phase II 60 advanced carcinoid 59 By Thomas Gryta 59 AEG# 58 multi kinase inhibitor 58 JAK1 58 Initiate Phase 58 Presents Positive 58 GVAX R 57 Penguin NF P 57 Completes Enrollment 57 Daclizumab 57 Voreloxin 57 metastatic castrate resistant 57 HGS ETR2 57 drug conjugate 57 metastatic hormone refractory 57 Dapagliflozin 57 Initiates Phase 57 metastatic castration resistant 57 Rosetta dependence 57 SAR# [004] 57 Receives Orphan Drug Designation 56 Epratuzumab 56 CYC# 56 ALN TTR 56 deforolimus 56 IMC #B 56 Proxinium TM 56 Ixempra 56 HGS ETR1 56 Pivotal Phase 56 CK # novel 56 R bortezomib 56 targeting CD# 55 OXi# 55 BZL# 55 Jewtastic Staff 55 luteinizing hormone releasing 55 Naproxcinod 55 Factor VIIa 55 Drug Candidate 55 PEG SN# 55 II Clinical Trial 55 operates NYSE Liffe 55 IMC A# 55 liposomal formulation 55 registrational trial 54 CA4P 54 By TheImproper 54 pertuzumab 54 welcome Bostik 54 Amrubicin 54 proteasome inhibitor 54 forodesine 54 Nexavar ® 54 Pivotal Phase III 54 INCB# [001] 54 Imprime PGG 54 By Frankie Genchi 53 Phase Ib II 53 By AAyles 53 Inc. Nasdaq IMGN 53 Pralatrexate 53 plus prednisone 53 Patient Enrollment 53 Vandetanib 53 TELINTRA 53 Bortezomib 53 Text bluestar 53 KNS # 53 Valuation Ratios eg 52 NASDAQ LGND 52 CCX# 52 Preclinical Data 52 By newsdesk Posted 52 EGFR expressing mCRC 52 docetaxel chemotherapy 52 CR# vcMMAE 52 selective inhibition 51 pstrelow@thestate.com 51 PXD# 51 Phase 2b clinical trials 51 sunitinib malate 51 carboplatin paclitaxel 51 Clinical Trial Results 51 RGB # 51 elotuzumab 51 Analysis lays bare 51 relapsed multiple myeloma 51 Myelofibrosis 51 Phase IIb trials 51 ganetespib 51 TOCOSOL Paclitaxel 50 Estonia Netherlands 50 TLR9 agonist